Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Antibodies”

60 trials

Showing 20 of 60 results

Not applicableStudy completedNCT04033887
What this trial is testing

Evaluation Study of RDTs Detecting Antibodies Against HCV

Who this might be right for
Hepatitis C
Foundation for Innovative New Diagnostics, Switzerland 1,710
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Early research (Phase 1)Study completedNCT00503347
What this trial is testing

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Who this might be right for
Hepatitis C VirusHiv Infections
Peregrine Pharmaceuticals 24
Not applicableUnknownNCT03892681
What this trial is testing

Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma

Who this might be right for
Chronic HepatitisLiver Cirrhosis
Yonsei University 129
Not applicableEnded earlyNCT02084719
What this trial is testing

Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

Who this might be right for
Active or Ex-injection Drug UsersIndication of Hepatitis C Screening
Centre hospitalier de l'Université de Montréal (CHUM) 67
Not applicableStudy completedNCT06357819
What this trial is testing

INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation

Who this might be right for
Hepatitis C
bioLytical Laboratories 405
Early research (Phase 1)Study completedNCT00128271
What this trial is testing

Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 32
Early research (Phase 1)Study completedNCT00343525
What this trial is testing

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Peregrine Pharmaceuticals 24
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Large-scale testing (Phase 3)Study completedNCT00133276
What this trial is testing

Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

Who this might be right for
Hepatitis C
Foundation for Liver Research 80
Early research (Phase 1)UnknownNCT00300807
What this trial is testing

Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
XTL Biopharmaceuticals 36
Not applicableUnknownNCT05906459
What this trial is testing

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

Who this might be right for
Hepatitis C Virus Infection
Huashan Hospital 20,000
Not applicableStudy completedNCT00004851
What this trial is testing

Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies

Who this might be right for
Hepatitis C
National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Study completedNCT01008358
What this trial is testing

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis C Virus Chronic Infection
Clinica Universidad de Navarra, Universidad de Navarra 20
Post-approval studies (Phase 4)Study completedNCT01285050
What this trial is testing

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT00901524
What this trial is testing

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Who this might be right for
Hepatitis
ANRS, Emerging Infectious Diseases 58
Not applicableNot Yet RecruitingNCT06492018
What this trial is testing

Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population

Who this might be right for
Hepatitis C
Abbott Rapid Dx 150
Testing effectiveness (Phase 2)Study completedNCT01707472
What this trial is testing

Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis

Who this might be right for
Liver FibrosisHepatitis CHIV+1 more
Gilead Sciences 18
Not applicableStudy completedNCT03566966
What this trial is testing

Autoantibodies and Direct-acting Antivirals

Who this might be right for
Viral Hepatitis CTherapy Adverse Effect
University of Bari 191
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation